Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
ACTA2 and prostate cancer are reported together in 1 article.
Gene
ACTA2
- HGNC
- HGNC:130
7articles
7mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
Phenotype
Prostate cancer
218articles
218mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
1 records shown · first 60Integrative bioinformatics and drug repurposing for metastatic prostate cancer: identifying novel therapeutic targets by transcriptional profiling and molecular Modeling.
PMID 40843941 | DOI 10.1093/intbio/zyaf016 · Integrative biology : quantitative biosciences from nano to macro · 2025 · 4 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ACTA2 | “Additionally, ACTA2, MYLK, and CNN1 were recognized as potential therapeutic targets for these compounds.” | 0.98 | hgnc_dict_v1 |
| phenotype | prostate cancer | “Integrative bioinformatics and drug repurposing for metastatic prostate cancer: identifying novel therapeutic targets by transcriptional profiling and molecular Modeling.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | MYLK | “Additionally, ACTA2, MYLK, and CNN1 were recognized as potential therapeutic targets for these compounds.” | 0.98 | hgnc_dict_v1 |
| gene | CNN1 | “Additionally, ACTA2, MYLK, and CNN1 were recognized as potential therapeutic targets for these compounds.” | 0.98 | hgnc_dict_v1 |